TRGM OTC
Targeted Medical Pharma, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -90.0%
1Y: -90.0%
3Y: -95.0%
5Y: -99.8%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$1M
-263.9% ▼
Capital Expenditures
$3
+25.0% ▲
5Y CAGR: -91.6%
Free Cash Flow
-$1M
-263.9% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$71K
+114.8% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$4M | -$10M | -$9M | -$4M | -$3M |
| Depreciation & Amort. | $458K | $436K | $412K | $402K | $231K |
| Stock-Based Comp. | $1M | $1M | $745K | $656K | $95K |
| Change in Working Capital | $2M | $2M | $220K | $3M | $1M |
| Other Non-Cash Items | $41K | $7M | $222K | $419K | $350K |
| Operating Cash Flow | -$3M | -$2M | -$2M | $780K | -$1M |
| — Investing Activities — | |||||
| Capital Expenditures | -$82K | -$116K | -$38K | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $244K | $0 | $0 | $0 | $0 |
| Other Investing | -$430K | -$179K | -$83K | $0 | $0 |
| Investing Cash Flow | -$268K | -$295K | -$121K | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $2M | $3M | $2M | -$2M | $1M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | -$268K | $0 | $0 | $0 |
| Financing Cash Flow | $2M | $3M | $2M | -$1M | $1M |
| Net Change in Cash | -$649K | $179K | $165K | -$480K | $71K |
| Cash End of Period | $147K | $327K | $492K | $12K | $83K |
| Free Cash Flow | -$3M | -$3M | -$2M | $780K | -$1M |